A univariate analysis indicated that ATF3 expression (HR 0.454; 95% CI 0.252-0.817; p=0.008), clinical stage (HR 2.354; 95% CI 1.336-4.148; p=0.003), N stage (HR 2.230; 95% CI 1.539-3.497; p<0.001), M stage (HR 9.851; 95% CI 2.233-43.466; p=0.003), and tumor size (HR 0.520; 95% CI 0.295-0.919; p=0.024) were significantly correlated with OS (Table 2). The gene discussed is ATF3; the disease is neoplasm.